(688073)"BIDE PHARMATECH CO., LTD."Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2026
Filed with SSE · Stock code 688073 · · 5 pages · Chinese
Summary by 6ix AI
The meeting was held to discuss various proposals, including the use of surplus funds and the election of board members.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Bide Pharmatech Co. Ltd. on 6ix
Story so far
- (688073)"BIDE PHARMATECH CO., LTD."Announcement on Convening the 2026 Semi-annual Performance Briefing
- (688073)"BIDE PHARMATECH CO., LTD."Announcement on Resignation of the Securities Affairs Representative
- (688073)"BIDE PHARMATECH CO., LTD."Announcement on Use of Surplus Raised Funds and Remaining Over-raised Funds to Permanently Supplement Working Capital
Earlier from Bide Pharmatech
- (688073)"BIDE PHARMATECH CO., LTD."Announcement on Convening the 2026 Semi-annual Performance Briefing
- (688073)"BIDE PHARMATECH CO., LTD."Announcement on Resignation of the Securities Affairs Representative
- (688073)"BIDE PHARMATECH CO., LTD."Announcement on Use of Surplus Raised Funds and Remaining Over-raised Funds to Permanently Supplement Working Capital
- (688073)"BIDE PHARMATECH CO., LTD."Announcement on Election of New Board of Directors
- Notice on Convening the 3rd Extraordinary General Meeting in 2026
Follow Bide Pharmatech into a list and get an email when it puts out news.
Follow Bide Pharmatech